Results 221 to 230 of about 5,261 (261)

Kir4.1 channels contribute to astrocyte CO₂/H⁺-sensitivity and the drive to breathe. [PDF]

Commun Biol
Cleary CM, Browning JL, Armbruster M, Sobrinho CR, Strain ML, Jahanbani S, Soto-Perez J, Hawkins VE, Dulla CG, Olsen ML, Mulkey DK.   +10 more
europepmc   +1 more source

Partners in health and disease: pineal gland and purinergic signalling. [PDF]

Purinergic Signal
Markus RP, Sousa KS, Ulrich H, Ferreira ZS.   +3 more
europepmc   +1 more source

P2Y₁₁ receptor is a critical regulator of extracellular ATP-mediated premature senescence in lung fibroblasts: Implications of ER-Ca⁺² release/mitochondrial ROS production signaling pathway. [PDF]

Purinergic Signal
Shatat AS.
europepmc   +1 more source

Purinergic signaling promotes premature senescence. [PDF]

J Biol Chem
Volonte D, Benson CJ, Daugherty SL, Beckel JM, Trebak M, Galbiati F.   +5 more
europepmc   +1 more source

Purinergic Receptor Antagonists Inhibit Hemolysis Induced by <i>Clostridium perfringens</i> Alpha Toxin. [PDF]

Pathogens
Guo Z, Yue N, Chen M, Li J, Lv R, Wang J, Liu T, Huang J, Gao S, Li Y, Yuan B, Wang J, Kang L, Ji B, Xin W.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

PPADS: Physician-PArent Decision-Support for Neonatal Intensive Care

Medinfo, 2013
Family-centered care is becoming the new standard for Neonatal Intensive Care Unit (NICU) patients. In support of this, we developed the Physician PArent Decision Support System (PPADS), which provides clinical updates and predictions of clinical outcomes for infants in the NICU to the neonatologists, and provides an aid to parents for making difficult
M. Frize, E. Bariciak, Jeff Gilchrist
semanticscholar   +3 more sources

PPADS is a reversible competitive antagonist of the NAADP receptor.

Cell Calcium, 2007
NAADP has been shown to act as a second messenger in a wide range of systems from plants to mammalian cells. Although it had always been considered as a canonical second messenger, recent work has shown that it is also active when applied extracellularly.
R. Billington, A. Genazzani
semanticscholar   +4 more sources

PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses.

European Journal of Pharmacology, 1992
We have characterized PPADS (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid) as a novel antagonist which selectively blocks P2 purinoceptor-mediated responses in rabbit vas deferens at pre- and postjunctional sites. PPADS did not interact with alpha 1-adrenoceptors, muscarinic M2 and M3 receptors, histamine H1 and adenosine A1 receptors.
G. Lambrecht, T. Friebe, Ulrike Grimm, U. Windscheif, E. Bungardt, C. Hildebrandt, H. Bäumert, G. Spatz-Kümbel, E. Mutschler   +8 more
semanticscholar   +3 more sources

P2 receptor antagonist PPADS confers neuroprotection against glutamate/NMDA toxicity

Neuroscience Letters, 2005
The present study investigated the role of pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid tetrasodium salt (PPADS), a P2 receptor antagonist, in protecting mouse cerebellar granule neurons (CGNs) against glutamate/NMDA-induced neuronal death. Neurotoxicity caused by 50 microM glutamate or 200 microM NMDA was significantly reduced in CGNs treated
Yanpeng Lin, A. Desbois, Susan X. Jiang, S. Hou   +3 more
semanticscholar   +4 more sources

PPAD: A tool for presumption of atopic dermatitis

The Journal of Dermatology, 2011
AbstractAlthough it is a frequent disease, atopic dermatitis is poorly recognised and therefore under‐diagnosed. The aim of this study was to define and validate a convenient tool allowing presumption of atopic dermatitis for non‐dermatologists. A 20‐item questionnaire (PPAD) and an 8‐item short version (PPAD‐S) were developed in French by a board of ...
Misery, Laurent, Ortonne, Jean-Paul, Cambazard, Frédéric, Guillet, Gérard, Thomas, Luc, Lorette, Gérard, Durosier, Vincent, Rahhali, Nora, Auges, Marie, Taieb, Charles   +9 more
openaire   +4 more sources